According to this research, the circadian clock genes TIMELESS, CRY2, PER1, and RORα may be used as therapeutic targets, diagnostic and prognostic biomarkers, and indicators of prognosis for patients with HCC. The gene discussed is CLOCK; the disease is hepatocellular carcinoma.